Literature DB >> 32135399

A key control point in the T cell response to chronic infection and neoplasia: FOXO1.

Nimi Marcel1, Stephen M Hedrick2.   

Abstract

T cells able to control neoplasia or chronic infections display a signature gene expression profile similar or identical to that of central memory T cells. These cells have qualities of self-renewal and a plasticity that allow them to repeatedly undergo activation (growth, proliferation, and differentiation), followed by quiescence. It is these qualities that define the ability of T cells to establish an equilibrium with chronic infectious agents, and also preserve the ability of T cells to be re-activated (by checkpoint therapy) in response to malignant cancers. Here we describe distinctions between the forms of inhibition mediated by tumors and persistent viruses, we review the properties of T cells associated with long-term immunity, and we identify the transcription factor, FOXO1, as the control point for a program of gene expression that allows CD8+ T cells to undergo serial reactivation and self-renewal.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32135399      PMCID: PMC8793964          DOI: 10.1016/j.coi.2020.02.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  140 in total

Review 1.  The genetics of ageing.

Authors:  Cynthia J Kenyon
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

Review 2.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

Review 3.  T-cell exhaustion in allograft rejection and tolerance.

Authors:  Edward B Thorp; Christian Stehlik; M Javeed Ansari
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

4.  FoxO is a critical regulator of stem cell maintenance in immortal Hydra.

Authors:  Anna-Marei Boehm; Konstantin Khalturin; Friederike Anton-Erxleben; Georg Hemmrich; Ulrich C Klostermeier; Javier A Lopez-Quintero; Hans-Heinrich Oberg; Malte Puchert; Philip Rosenstiel; Jörg Wittlieb; Thomas C G Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

Review 5.  The evolutionary ecology of transmissible cancers.

Authors:  Beata Ujvari; Robert A Gatenby; Frédéric Thomas
Journal:  Infect Genet Evol       Date:  2016-02-06       Impact factor: 3.342

6.  Viral infections induce abundant numbers of senescent CD8 T cells.

Authors:  D Voehringer; C Blaser; P Brawand; D H Raulet; T Hanke; H Pircher
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  T cell factor-1 and β-catenin control the development of memory-like CD8 thymocytes.

Authors:  Archna Sharma; Qinghua Chen; Trang Nguyen; Qing Yu; Jyoti Misra Sen
Journal:  J Immunol       Date:  2012-04-15       Impact factor: 5.422

8.  miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation.

Authors:  Young Ho Ban; Se-Chan Oh; Sang-Hwan Seo; Seok-Min Kim; In-Pyo Choi; Philip D Greenberg; Jun Chang; Tae-Don Kim; Sang-Jun Ha
Journal:  Cell Rep       Date:  2017-09-12       Impact factor: 9.423

9.  An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance.

Authors:  Weiming Ouyang; Omar Beckett; Richard A Flavell; Ming O Li
Journal:  Immunity       Date:  2009-03-12       Impact factor: 31.745

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.